Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Neonatal sepsis: the microbiota pays a heavy price for antibiotic use
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Neonatal sepsis: the microbiota pays a heavy price for antibiotic use
Gastroenterology

Neonatal sepsis: the microbiota pays a heavy price for antibiotic use

Antibiotics
Pediatrics Gynecology Gastroenterology

How does neonatal antibiotic treatment affect an infant’s gut microbiota? When newborns require antibiotics, which cause the least damage? A randomized trial has provided answers to these questions.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail
Photo: Neonatal sepsis: the microbiota pays a heavy price for antibiotic use

About this article

Created 09 May 2022
Updated 17 May 2022

Colic, allergies, obesity, altered immune development... gut dysbiosis in newborns is associated with a wide range of health problems that may persist throughout life. Despite this, broad-spectrum antibiotics continue to be prescribed at a high rate (up to 10% of all neonates) because of suspected early-onset neonatal sepsis (sEONS).

1 in 1000

Currently, antibiotics are prescribed in 4-10% of all neonates, whereas only an estimated 1 in 1000 will develop a proven infection, likely resulting in unnecessary treatment of >90% of all treated children.

Randomized trial of three antibiotic combinations 

To better understand the effects of early-life antibiotics, a randomized trial was conducted in 147 infants treated with broad-spectrum antibiotics during their first week of life. The infants were randomized to receive one of three commonly prescribed intravenous antibiotic combinations, namely penicillin + gentamicin, co-amoxiclav + gentamicin or amoxicillin + cefotaxime. Eighty healthy infants (not treated with antibiotics) served as controls.

17.11.2020 The Janus face of Antibiotics: Life Savers & Microbiota Disrupters Read more

Diversity down, resistance up

Microbial diversity was similar in all infants before antibiotic treatment, but α-diversity in the treated infants fell dramatically immediately after treatment. Subsequently, their α-diversity slowly recovered, though it remained significantly lower during the first year of life. The composition of the gut microbiota was also impacted. Facultative anaerobic genera such as Escherichia and Staphylococcus were abundant in the first samples collected directly after birth, rapidly followed by Bifidobacterium. Subsequent abundances depended on whether the infant received antibiotics: in treated infants, Bifidobacterium spp., Escherichia, Staphylococcus spp., and Bacteroides were less abundant, while Klebsiella and Enterococcus spp. were more abundant. Lastly, the team observed more antimicrobial resistance genes in the treated children.

more than 90% of infants are treated with antibiotics when EONS is suspected but not firmly established.

Not all antibiotics are the same

Significant differences were observed between the three antibiotic regimes, with the “amoxicillin + cefotaxime” combination having the greatest effect on gut microbiota composition and antimicrobial resistance, and “penicillin + gentamicin” having the least effect. As a result, the researchers suggest that treatment with the latter combination should be reconsidered in neonatal wards where it is not currently popular.

In each case, the effects of antibiotic treatment were more pronounced and prolonged than expected, probably because the microbiota of infants is still developing (whereas previous studies had focused on older children). Currently, more than 90% of infants are treated with antibiotics when EONS is suspected but not firmly established. According to the authors, this underlines the importance of improving the accuracy of EONS diagnosis, since the consequences of treatment are serious and potentially long-lasting.

Sources

Reyman M, van Houten MA, Watson RL, et al. Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial. Nat Commun. 2022 Feb 16;13(1):893. 

Tags
Antibiotics Dysbiosis Baby health Diversity

en_view en_sources

    See also

    Antibiotics and cesarean delivery: how do they affect the newborn microbiota?
    Discovery of a “grey area” between bacteriostatic and bactericidal antibiotics
    Created 09 May 2022
    Updated 17 May 2022

    About this article

    To know more about this topic.

    Main topic

    Antibiotics

    Medical practice

    Pediatrics Gynecology Gastroenterology

    Content type

    News
    Gastroenterology

    The blue poop challenge: a reliable method to evaluate gut transit?

    By Pr. Gianluca Ianiro Gastroenterology Department, Fondazione Policlinico Universitario Agostino Gemelli- ...

    Find out more

    New perspectives in autism: the role of microbiota in social communication

    Overview By Dr. Vincent Trebossen Child and Adolescent P...

    Find out more

    Gut microbiota #15

    By Pr. Markku Voutilainen Turku University Faculty of Medicine; Turku University Hospital, Department of Ga...

    Find out more

    Microbiome topics at gastro 2021

    Congress Review By Pr. Eamonn M M Quigley Lynda K and David M Underwood Center for Digestive Disorders, Di...

    Find out more

    Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumours

    Commented articles - Adults' section By Pr. Harry Sokol ...

    Find out more

    Microbiota in covid-19 pandemic

    Overview By Pr. Conceição Calhau NOVA Medical School, New University of Lisbon, Portugal By Pr. Pedro Povo...

    Find out more

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial porti...

    Find out more

    From diarrhea to chronic diseases: the well-documented consequences of antibiotic-related gut microbiota dysbiosis

    Antibiotic treatment may sometimes take place without any...

    Find out more

    Continue reading

    News
    22.11.2021

    Irritable bowel syndrome: is fecal microbiota transplantation effective in the long term?

    Read the article
    Cancer du pancréas : un diagnostic précoce non invasif grâce au microbiote fécal ?
    16.06.2022

    Pancreatic cancer: non-invasive early diagnosis thanks to the fecal microbiota?

    Read the article
    Photo: Régime méditerranéen « vert » : quels liens entre santé cardiométabolique et microbiote intestinal ?
    10.06.2022

    Green Mediterranean diet: what links between cardiometabolic health and gut microbiota?

    Read the article
    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria
    02.06.2022

    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria

    Read the article
    18.05.2022

    Gut microbiota and vitamin D: a promising team in the fight against osteoporosis?

    Read the article
    26.04.2022

    Severe obesity: the vicious circle of biotin metabolism

    Read the article
    22.04.2022

    SCFAs: new intestinal markers of Parkinson’s disease?

    Read the article
    15.04.2022

    Multiple sclerosis and microbiota: does meat consumption play a role?

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Photo: Postménopause : l'action bénéfique de l'estradiol sur le microbiote vaginal
    22.06.2022

    Postmenopause: the beneficial action of estradiol on the vaginal microbiota

    Read the article
    WMD_Foundation KOL USA 2018
    17.06.2022

    Dr. Yang (USA winner 2018): Gut microbiota & gut brain axis

    Read the article
    WMD_Foundation KOL USA 2017
    17.06.2022

    Dr. Singh (USA winner 2017): Microbiota & polyphenols

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo